We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
73 hedge funds and large institutions have $25M invested in Atossa Therapeutics in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 7 increasing their positions, 33 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.66% less ownership
Funds ownership: 1.89% → 1.23% (-0.66%)
7% less call options, than puts
Call options by funds: $1.92M | Put options by funds: $2.05M
12% less funds holding
Funds holding: 83 → 73 (-10)
33% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 24
45% less capital invested
Capital invested by funds: $45.4M → $25M (-$20.4M)
79% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 33
Holders
73
Holders Change
-10
Holders Change %
-12.05%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
7
Reduced
33
Closed
24
Calls
$1.92M
Puts
$2.05M
Net Calls
-$137K
Net Calls Change
+$166K
Top Buyers
| 1 |
LCM
Laurion Capital Management
New York
|
+$2.34M |
| 2 |
Millennium Management
New York
|
+$1.61M |
| 3 |
E
Ergoteles
New York
|
+$541K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$325K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$171K |
Top Sellers
| 1 |
BlackRock
New York
|
-$6.14M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$3.18M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.84M |
| 4 |
D.E. Shaw & Co
New York
|
-$1.66M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.06M |
